Detail Information of Microbiota Influence
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0155 Transporter Info | ||||
| Gene Name | SLC22B3 | ||||
| Transporter Name | Synaptic vesicle glycoprotein 2C | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Microbiota Influence of This DT (MBI) | |||||
|---|---|---|---|---|---|
|
Bacteria: Campylobacterota |
|||||
|
Genus: Helicobacter |
|||||
|
Helicobacter pylori |
Microbe Info |
Click to Show/Hide the Full List 1 Microbe Influence Related to This Species |
|||
|
Microbe Influence 1 |
Sequestration of human SLC22B3 substrates/drugs in the health condition | [1] | |||
|
Studied Tissue |
Stomach | ||||
|
In Vitro Model |
Human gastric epithelial cells | ||||
|
Detailed Description |
The Helicobacter pylori ATCC 700824 has been reported to sequester the drug L-dopamine, which limits the distribution of the drug in the body and its binding to the drug transporter SLC22B3, thereby affecting the efficacy, safety, or bioavailability of the drug. | ||||
| References | |||||
|---|---|---|---|---|---|
| 1 | In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?. J Pharm Pharmacol. 2009 Oct;61(10):1303-7. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.